Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for GMED

Stock Name	Globus Medical
Ticker	GMED(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US3795772082
LEI	5299003M2P4CIK0RF205

Show aggregate GMED holdings

News associated with GMED

Brokerages Set Globus Medical, Inc. (NYSE:GMED) PT at $87.64: Shares of Globus Medical, Inc. (NYSE:GMED – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the thirteen brokerages that are presently covering the firm, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average […] - 2025-09-22 02:58:55
Globus Medical, Inc. (NYSE:GMED) Holdings Decreased by Maryland State Retirement & Pension System: Maryland State Retirement & Pension System trimmed its position in Globus Medical, Inc. (NYSE:GMED – Free Report) by 18.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,232 shares of the medical device company’s stock after selling 1,163 shares during the quarter. Maryland […] - 2025-08-17 05:16:58
Mitsubishi UFJ Asset Management Co. Ltd. Increases Stock Position in Globus Medical, Inc. (NYSE:GMED): Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in Globus Medical, Inc. (NYSE:GMED – Free Report) by 4.4% during the first quarter, HoldingsChannel reports. The firm owned 8,440 shares of the medical device company’s stock after buying an additional 355 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Globus Medical […] - 2025-08-14 05:27:14
Vanguard Group Inc. Purchases 45,248 Shares of Globus Medical, Inc. (NYSE:GMED): Vanguard Group Inc. increased its position in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 0.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,909,082 shares of the medical device company’s stock after acquiring an additional 45,248 shares during the period. […] - 2025-08-13 05:43:02
Globus Medical (NYSE:GMED) Upgraded at Wall Street Zen: Wall Street Zen upgraded shares of Globus Medical (NYSE:GMED – Free Report) from a hold rating to a buy rating in a research report released on Saturday morning. Several other equities research analysts also recently weighed in on the company. Truist Financial cut their price target on Globus Medical from $80.00 to $68.00 and set […] - 2025-08-12 04:16:56
Globus Medical, Inc. (NYSE:GMED) Shares Sold by Choreo LLC: Choreo LLC decreased its holdings in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 39.8% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,591 shares of the medical device company’s stock after selling 3,693 shares during the quarter. Choreo LLC’s holdings in […] - 2025-07-29 05:00:54
HighPoint Advisor Group LLC Sells 325 Shares of Globus Medical, Inc. (NYSE:GMED): HighPoint Advisor Group LLC cut its holdings in Globus Medical, Inc. (NYSE:GMED – Free Report) by 7.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,121 shares of the medical device company’s stock after selling 325 shares during the quarter. HighPoint […] - 2025-07-24 06:28:56
Needham & Company LLC Reiterates “Hold” Rating for Globus Medical (NYSE:GMED): Needham & Company LLC reissued their hold rating on shares of Globus Medical (NYSE:GMED – Free Report) in a report issued on Monday morning,Benzinga reports. Several other equities research analysts have also issued reports on the stock. BTIG Research restated a “neutral” rating on shares of Globus Medical in a research note on Tuesday, May […] - 2025-07-22 07:13:04
M&T Bank Corp Sells 5,218 Shares of Globus Medical, Inc. (NYSE:GMED): M&T Bank Corp cut its holdings in Globus Medical, Inc. (NYSE:GMED – Free Report) by 51.8% during the first quarter, Holdings Channel reports. The firm owned 4,849 shares of the medical device company’s stock after selling 5,218 shares during the quarter. M&T Bank Corp’s holdings in Globus Medical were worth $355,000 at the end of […] - 2025-07-18 04:36:53
Mutual of America Capital Management LLC Reduces Holdings in Globus Medical, Inc. (NYSE:GMED): Mutual of America Capital Management LLC trimmed its holdings in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 2.6% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,538 shares of the medical device company’s stock after selling […] - 2025-07-17 06:09:47
Bank of New York Mellon Corp Has $85.19 Million Stake in Globus Medical, Inc. (NYSE:GMED): Bank of New York Mellon Corp lowered its stake in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 14.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,163,834 shares of the medical device company’s stock after selling 189,797 […] - 2025-07-11 06:44:57
Globus Medical, Inc. (NYSE:GMED) Shares Acquired by Principal Financial Group Inc.: Principal Financial Group Inc. lifted its holdings in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 0.4% during the 1st quarter, Holdings Channel.com reports. The firm owned 261,592 shares of the medical device company’s stock after acquiring an additional 919 shares during the period. Principal Financial Group Inc.’s holdings in Globus Medical were […] - 2025-07-11 05:30:56
Allspring Global Investments Holdings LLC Purchases New Holdings in Globus Medical, Inc. (NYSE:GMED): Allspring Global Investments Holdings LLC acquired a new position in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) during the 1st quarter, Holdings Channel reports. The firm acquired 10,265 shares of the medical device company’s stock, valued at approximately $753,000. Several other hedge funds and other institutional investors also recently bought and sold shares […] - 2025-07-10 04:36:51
Teacher Retirement System of Texas Sells 9,724 Shares of Globus Medical, Inc. (NYSE:GMED): Teacher Retirement System of Texas decreased its position in Globus Medical, Inc. (NYSE:GMED – Free Report) by 16.9% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 47,748 shares of the medical device company’s stock after selling 9,724 shares during the […] - 2025-07-09 05:32:57
First Horizon Advisors Inc. Has $64,000 Stock Position in Globus Medical, Inc. (NYSE:GMED): First Horizon Advisors Inc. raised its stake in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 30.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 872 shares of the medical device company’s stock after purchasing an additional 206 shares during the quarter. […] - 2025-07-08 05:04:46
8,021 Shares in Globus Medical, Inc. (NYSE:GMED) Purchased by Illinois Municipal Retirement Fund: Illinois Municipal Retirement Fund acquired a new position in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) in the 1st quarter, Holdings Channel reports. The fund acquired 8,021 shares of the medical device company’s stock, valued at approximately $587,000. Several other large investors have also made changes to their positions in GMED. Proficio Capital […] - 2025-07-04 04:44:48
KBC Group NV Raises Stake in Globus Medical, Inc. (NYSE:GMED): KBC Group NV grew its stake in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 1.8% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 47,009 shares of the medical device company’s stock after acquiring an additional 826 shares during the […] - 2025-07-03 05:40:54
Diversified Trust Co Has $887,000 Position in Globus Medical, Inc. (NYSE:GMED): Diversified Trust Co decreased its stake in Globus Medical, Inc. (NYSE:GMED – Free Report) by 5.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 12,110 shares of the medical device company’s stock after selling 701 shares during the period. Diversified Trust […] - 2025-06-30 05:10:56
Oppenheimer Asset Management Inc. Has $1.91 Million Holdings in Globus Medical, Inc. (NYSE:GMED): Oppenheimer Asset Management Inc. raised its holdings in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 8.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,097 shares of the medical device company’s stock after purchasing an additional 2,103 shares during […] - 2025-06-27 05:05:02
State of Alaska Department of Revenue Acquires 350 Shares of Globus Medical, Inc. (NYSE:GMED): State of Alaska Department of Revenue boosted its position in Globus Medical, Inc. (NYSE:GMED – Free Report) by 2.7% in the 1st quarter, Holdings Channel reports. The firm owned 13,320 shares of the medical device company’s stock after buying an additional 350 shares during the quarter. State of Alaska Department of Revenue’s holdings in Globus […] - 2025-06-27 04:32:53
Globus Medical, Inc. (NYSE:GMED) Shares Sold by Johnson Investment Counsel Inc.: Johnson Investment Counsel Inc. lowered its stake in Globus Medical, Inc. (NYSE:GMED – Free Report) by 14.7% during the first quarter, HoldingsChannel reports. The firm owned 3,341 shares of the medical device company’s stock after selling 577 shares during the quarter. Johnson Investment Counsel Inc.’s holdings in Globus Medical were worth $245,000 as of its […] - 2025-06-23 04:56:57
Parallel Advisors LLC Raises Stock Holdings in Globus Medical, Inc. (NYSE:GMED): Parallel Advisors LLC lifted its position in Globus Medical, Inc. (NYSE:GMED – Free Report) by 62.1% in the first quarter, Holdings Channel reports. The firm owned 504 shares of the medical device company’s stock after buying an additional 193 shares during the period. Parallel Advisors LLC’s holdings in Globus Medical were worth $37,000 at the […] - 2025-06-10 04:48:50
Versant Capital Management Inc Acquires 494 Shares of Globus Medical, Inc. (NYSE:GMED): Versant Capital Management Inc increased its stake in Globus Medical, Inc. (NYSE:GMED – Free Report) by 932.1% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 547 shares of the medical device company’s stock after acquiring an additional 494 shares during the quarter. […] - 2025-06-06 05:45:06
JMP Securities Reiterates Market Perform Rating for Globus Medical (NYSE:GMED): Globus Medical (NYSE:GMED – Get Free Report)‘s stock had its “market perform” rating reissued by analysts at JMP Securities in a research note issued to investors on Tuesday,Benzinga reports. GMED has been the topic of several other research reports. Piper Sandler decreased their price objective on Globus Medical from $100.00 to $80.00 and set an […] - 2025-05-29 03:02:55
BTIG Research Reiterates “Neutral” Rating for Globus Medical (NYSE:GMED): Globus Medical (NYSE:GMED – Get Free Report)‘s stock had its “neutral” rating restated by analysts at BTIG Research in a research report issued on Tuesday, Marketbeat Ratings reports. Several other analysts have also weighed in on the company. Stifel Nicolaus upped their target price on Globus Medical from $92.00 to $94.00 and gave the company […] - 2025-05-29 02:15:09
Globus Medical, Inc. (NYSE:GMED) Shares Purchased by ProShare Advisors LLC: ProShare Advisors LLC grew its position in Globus Medical, Inc. (NYSE:GMED – Free Report) by 6.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,514 shares of the medical device company’s stock after acquiring an additional 321 shares during the […] - 2025-05-27 05:07:07
Quantinno Capital Management LP Has $387,000 Stock Holdings in Globus Medical, Inc. (NYSE:GMED): Quantinno Capital Management LP grew its position in Globus Medical, Inc. (NYSE:GMED – Free Report) by 20.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,673 shares of the medical device company’s stock after purchasing an additional 784 shares during the period. Quantinno Capital […] - 2025-05-26 04:58:54
Cetera Investment Advisers Boosts Holdings in Globus Medical, Inc. (NYSE:GMED): Cetera Investment Advisers raised its holdings in Globus Medical, Inc. (NYSE:GMED – Free Report) by 13.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 8,263 shares of the medical device company’s stock after buying an additional 1,008 shares during the quarter. Cetera Investment […] - 2025-05-26 04:21:03
Deutsche Bank AG Has $3.18 Million Stock Holdings in Globus Medical, Inc. (NYSE:GMED): Deutsche Bank AG boosted its holdings in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 3.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 38,441 shares of the medical device company’s stock after buying an additional 1,157 shares during the quarter. […] - 2025-05-21 04:42:56
Globus Medical (NYSE:GMED) to Repurchase $500.00 million in Outstanding Stock: Globus Medical (NYSE:GMED – Get Free Report) announced that its Board of Directors has approved a stock buyback plan on Thursday, May 15th, RTT News reports. The company plans to buyback $500.00 million in outstanding shares. This buyback authorization permits the medical device company to purchase up to 6.3% of its shares through open market […] - 2025-05-16 02:10:45

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc GMED holdings

Date	Number of GMED Shares Held	Base Market Value of GMED Shares	Local Market Value of GMED Shares	Change in GMED Shares Held	Change in GMED Base Value	Current Price per GMED Share Held	Previous Price per GMED Share Held
2026-01-15 (Thursday)	13,554	USD 1,272,585	USD 1,272,585	2,080	USD 211,699	USD 93.89	USD 92.46
2026-01-14 (Wednesday)	11,474	USD 1,060,886	USD 1,060,886	40	USD 29,997	USD 92.46	USD 90.16
2026-01-13 (Tuesday)	11,434	USD 1,030,889	USD 1,030,889	0	USD -17,837	USD 90.16	USD 91.72
2026-01-12 (Monday)	11,434	USD 1,048,726	USD 1,048,726	0	USD -31,444	USD 91.72	USD 94.47
2026-01-09 (Friday)	11,434	USD 1,080,170	USD 1,080,170	0	USD -1,715	USD 94.47	USD 94.62
2026-01-08 (Thursday)	11,434	USD 1,081,885	USD 1,081,885	40	USD 50,272	USD 94.62	USD 90.54
2026-01-07 (Wednesday)	11,394	USD 1,031,613	USD 1,031,613	0	USD -31,333	USD 90.54	USD 93.29
2026-01-06 (Tuesday)	11,394	USD 1,062,946	USD 1,062,946	0	USD 32,131	USD 93.29	USD 90.47
2026-01-05 (Monday)	11,394	USD 1,030,815	USD 1,030,815	0	USD 36,119	USD 90.47	USD 87.3
2026-01-02 (Friday)	11,394	USD 994,696	USD 994,696	0	USD -114	USD 87.3	USD 87.31
2025-12-31 (Wednesday)	11,394	USD 994,810	USD 994,810	0	USD -6,837	USD 87.31	USD 87.91

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of GMED by Blackrock for IE00B3VWM098

Show aggregate share trades of GMED

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2026-01-15 BUY 2,080 94.030 92.490 92.644 USD 192,700 73.61
2026-01-14 BUY 40 92.620 89.180 89.524 USD 3,581 73.53
2026-01-08 BUY 40 101.397 94.020 94.758 USD 3,790 73.20
2025-12-23 SELL -40 89.850 88.520 88.653 USD -3,546 72.50 Loss of -646 on sale
2025-12-03 SELL -200 90.260 87.700 87.956 USD -17,591 71.48 Loss of -3,295 on sale
2025-12-02 BUY 80 89.842 88.280 88.436 USD 7,075 71.40
2025-11-25 SELL -120 91.740 88.000 88.374 USD -10,605 70.92 Loss of -2,094 on sale
2025-11-24 SELL -120 89.330 86.075 86.400 USD -10,368 70.84 Loss of -1,867 on sale
2025-11-17 SELL -440 84.910 82.670 82.894 USD -36,473 70.51 Loss of -5,447 on sale
2025-11-12 SELL -40 86.260 84.545 84.716 USD -3,389 70.30 Loss of -577 on sale
2025-11-06 SELL -40 62.270 60.380 60.569 USD -2,423 70.12 Profit of 382 on sale
2025-11-05 SELL -400 61.850 60.260 60.419 USD -24,168 70.16 Profit of 3,897 on sale
2025-11-04 SELL -80 62.100 60.640 60.786 USD -4,863 70.21 Profit of 754 on sale
2025-11-03 SELL -80 61.230 59.520 59.691 USD -4,775 70.25 Profit of 845 on sale
2025-10-28 BUY 120 62.750 64.320 64.163 USD 7,700 70.45
2025-10-24 SELL -40 62.290 63.270 63.172 USD -2,527 70.53 Profit of 294 on sale
2025-10-15 BUY 240 58.330 59.140 59.059 USD 14,174 70.92
2025-10-02 BUY 40 58.060 58.570 58.519 USD 2,341 71.05
2025-09-30 BUY 80 57.270 57.420 57.405 USD 4,592 71.20
2025-08-21 SELL -40 60.500 61.050 60.995 USD -2,440 71.63 Profit of 426 on sale
2025-07-31 BUY 120 52.630 53.310 53.242 USD 6,389 71.81
2025-06-30 SELL -80 59.020 59.390 59.353 USD -4,748 73.82 Profit of 1,157 on sale
2025-06-25 SELL -40 58.190 59.040 58.955 USD -2,358 74.14 Profit of 607 on sale
2025-06-20 SELL -80 57.870 58.610 58.536 USD -4,683 74.48 Profit of 1,276 on sale
2025-05-23 BUY 40 58.960 59.180 59.158 USD 2,366 77.01
2025-05-19 SELL -40 61.050 61.120 61.113 USD -2,445 77.59 Profit of 659 on sale
2025-05-15 SELL -120 57.820 58.460 58.396 USD -7,008 77.91 Profit of 2,342 on sale
2025-05-12 SELL -80 59.010 59.460 59.415 USD -4,753 78.44 Profit of 1,522 on sale
2025-04-30 SELL -40 71.770 71.890 71.878 USD -2,875 79.14 Profit of 290 on sale
2025-04-24 SELL -80 73.070 73.630 73.574 USD -5,886 79.40 Profit of 466 on sale
2025-04-17 SELL -40 71.010 71.800 71.721 USD -2,869 79.86 Profit of 326 on sale
2025-04-15 SELL -120 72.350 73.450 73.340 USD -8,801 80.04 Profit of 804 on sale
2025-04-14 SELL -120 72.980 74.340 74.204 USD -8,904 80.11 Profit of 709 on sale
2025-04-09 SELL -160 74.280 75.470 75.351 USD -12,056 80.37 Profit of 803 on sale
2025-04-07 SELL -280 70.750 72.690 72.496 USD -20,299 80.62 Profit of 2,274 on sale
2025-04-04 SELL -400 68.830 70.280 70.135 USD -28,054 80.76 Profit of 4,249 on sale
2025-03-31 BUY 40 73.200 73.610 73.569 USD 2,943 81.00
2025-03-19 SELL -80 73.340 73.430 73.421 USD -5,874 81.73 Profit of 665 on sale
2025-03-14 SELL -240 71.040 71.250 71.229 USD -17,095 82.16 Profit of 2,624 on sale
2025-03-13 SELL -80 69.680 72.150 71.903 USD -5,752 82.34 Profit of 835 on sale
2025-03-12 SELL -1,360 71.300 74.730 74.387 USD -101,166 82.50 Profit of 11,032 on sale
2025-03-07 SELL -80 77.410 78.090 78.022 USD -6,242 82.82 Profit of 384 on sale
2025-03-06 SELL -120 76.310 78.340 78.137 USD -9,376 82.92 Profit of 574 on sale
2025-03-03 SELL -40 79.250 81.230 81.032 USD -3,241 83.12 Profit of 84 on sale
2025-02-28 SELL -240 80.320 80.460 80.446 USD -19,307 83.17 Profit of 653 on sale
2025-02-26 SELL -40 80.010 80.990 80.892 USD -3,236 83.30 Profit of 96 on sale
2025-02-25 SELL -120 79.580 80.540 80.444 USD -9,653 83.36 Profit of 350 on sale
2025-02-18 BUY 200 84.830 84.990 84.974 USD 16,995 83.43
2025-02-13 BUY 40 84.130 84.380 84.355 USD 3,374 83.39
2025-02-12 BUY 40 84.010 84.340 84.307 USD 3,372 83.38
2025-02-11 BUY 120 84.280 87.040 86.764 USD 10,412 83.36
2025-02-06 BUY 360 87.950 92.410 91.964 USD 33,107 83.08
2025-01-27 BUY 40 91.980 92.660 92.592 USD 3,704 81.02
2024-12-30 BUY 200 82.670 83.440 83.363 USD 16,673 80.24
2024-12-06 BUY 160 83.320 83.720 83.680 USD 13,389 79.96
2024-12-05 BUY 40 83.090 84.130 84.026 USD 3,361 79.85
2024-12-04 BUY 200 84.410 85.920 85.769 USD 17,154 79.69
2024-11-29 BUY 200 85.610 86.000 85.961 USD 17,192 79.07
2024-11-27 BUY 160 85.290 85.740 85.695 USD 13,711 78.53
2024-11-26 BUY 40 84.530 84.920 84.881 USD 3,395 78.26
2024-11-25 SELL -1,344 84.490 85.330 85.246 USD -114,571 77.96 Loss of -9,793 on sale
2024-11-21 BUY 220 84.910 85.010 85.000 USD 18,700 77.24
2024-11-20 BUY 132 83.590 83.910 83.878 USD 11,072 76.88
2024-11-18 BUY 528 81.830 82.390 82.334 USD 43,472 76.17
2024-11-12 BUY 352 83.420 83.510 83.501 USD 29,392 75.69
2024-11-08 BUY 220 80.880 81.900 81.798 USD 17,996 75.32
2024-11-07 BUY 660 81.970 82.930 82.834 USD 54,670 74.81
2024-11-06 BUY 88 82.710 84.870 84.654 USD 7,450 74.15
2024-10-31 BUY 44 73.540 74.720 74.602 USD 3,282 73.88
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2026-01-15	BUY	2,080	94.030	92.490	92.644	USD 192,700	73.61
2026-01-14	BUY	40	92.620	89.180	89.524	USD 3,581	73.53
2026-01-08	BUY	40	101.397	94.020	94.758	USD 3,790	73.20
2025-12-23	SELL	-40	89.850	88.520	88.653	USD -3,546	72.50 Loss of -646 on sale
2025-12-03	SELL	-200	90.260	87.700	87.956	USD -17,591	71.48 Loss of -3,295 on sale
2025-12-02	BUY	80	89.842	88.280	88.436	USD 7,075	71.40
2025-11-25	SELL	-120	91.740	88.000	88.374	USD -10,605	70.92 Loss of -2,094 on sale
2025-11-24	SELL	-120	89.330	86.075	86.400	USD -10,368	70.84 Loss of -1,867 on sale
2025-11-17	SELL	-440	84.910	82.670	82.894	USD -36,473	70.51 Loss of -5,447 on sale
2025-11-12	SELL	-40	86.260	84.545	84.716	USD -3,389	70.30 Loss of -577 on sale
2025-11-06	SELL	-40	62.270	60.380	60.569	USD -2,423	70.12 Profit of 382 on sale
2025-11-05	SELL	-400	61.850	60.260	60.419	USD -24,168	70.16 Profit of 3,897 on sale
2025-11-04	SELL	-80	62.100	60.640	60.786	USD -4,863	70.21 Profit of 754 on sale
2025-11-03	SELL	-80	61.230	59.520	59.691	USD -4,775	70.25 Profit of 845 on sale
2025-10-28	BUY	120	62.750	64.320	64.163	USD 7,700	70.45
2025-10-24	SELL	-40	62.290	63.270	63.172	USD -2,527	70.53 Profit of 294 on sale
2025-10-15	BUY	240	58.330	59.140	59.059	USD 14,174	70.92
2025-10-02	BUY	40	58.060	58.570	58.519	USD 2,341	71.05
2025-09-30	BUY	80	57.270	57.420	57.405	USD 4,592	71.20
2025-08-21	SELL	-40	60.500	61.050	60.995	USD -2,440	71.63 Profit of 426 on sale
2025-07-31	BUY	120	52.630	53.310	53.242	USD 6,389	71.81
2025-06-30	SELL	-80	59.020	59.390	59.353	USD -4,748	73.82 Profit of 1,157 on sale
2025-06-25	SELL	-40	58.190	59.040	58.955	USD -2,358	74.14 Profit of 607 on sale
2025-06-20	SELL	-80	57.870	58.610	58.536	USD -4,683	74.48 Profit of 1,276 on sale
2025-05-23	BUY	40	58.960	59.180	59.158	USD 2,366	77.01
2025-05-19	SELL	-40	61.050	61.120	61.113	USD -2,445	77.59 Profit of 659 on sale
2025-05-15	SELL	-120	57.820	58.460	58.396	USD -7,008	77.91 Profit of 2,342 on sale
2025-05-12	SELL	-80	59.010	59.460	59.415	USD -4,753	78.44 Profit of 1,522 on sale
2025-04-30	SELL	-40	71.770	71.890	71.878	USD -2,875	79.14 Profit of 290 on sale
2025-04-24	SELL	-80	73.070	73.630	73.574	USD -5,886	79.40 Profit of 466 on sale
2025-04-17	SELL	-40	71.010	71.800	71.721	USD -2,869	79.86 Profit of 326 on sale
2025-04-15	SELL	-120	72.350	73.450	73.340	USD -8,801	80.04 Profit of 804 on sale
2025-04-14	SELL	-120	72.980	74.340	74.204	USD -8,904	80.11 Profit of 709 on sale
2025-04-09	SELL	-160	74.280	75.470	75.351	USD -12,056	80.37 Profit of 803 on sale
2025-04-07	SELL	-280	70.750	72.690	72.496	USD -20,299	80.62 Profit of 2,274 on sale
2025-04-04	SELL	-400	68.830	70.280	70.135	USD -28,054	80.76 Profit of 4,249 on sale
2025-03-31	BUY	40	73.200	73.610	73.569	USD 2,943	81.00
2025-03-19	SELL	-80	73.340	73.430	73.421	USD -5,874	81.73 Profit of 665 on sale
2025-03-14	SELL	-240	71.040	71.250	71.229	USD -17,095	82.16 Profit of 2,624 on sale
2025-03-13	SELL	-80	69.680	72.150	71.903	USD -5,752	82.34 Profit of 835 on sale
2025-03-12	SELL	-1,360	71.300	74.730	74.387	USD -101,166	82.50 Profit of 11,032 on sale
2025-03-07	SELL	-80	77.410	78.090	78.022	USD -6,242	82.82 Profit of 384 on sale
2025-03-06	SELL	-120	76.310	78.340	78.137	USD -9,376	82.92 Profit of 574 on sale
2025-03-03	SELL	-40	79.250	81.230	81.032	USD -3,241	83.12 Profit of 84 on sale
2025-02-28	SELL	-240	80.320	80.460	80.446	USD -19,307	83.17 Profit of 653 on sale
2025-02-26	SELL	-40	80.010	80.990	80.892	USD -3,236	83.30 Profit of 96 on sale
2025-02-25	SELL	-120	79.580	80.540	80.444	USD -9,653	83.36 Profit of 350 on sale
2025-02-18	BUY	200	84.830	84.990	84.974	USD 16,995	83.43
2025-02-13	BUY	40	84.130	84.380	84.355	USD 3,374	83.39
2025-02-12	BUY	40	84.010	84.340	84.307	USD 3,372	83.38
2025-02-11	BUY	120	84.280	87.040	86.764	USD 10,412	83.36
2025-02-06	BUY	360	87.950	92.410	91.964	USD 33,107	83.08
2025-01-27	BUY	40	91.980	92.660	92.592	USD 3,704	81.02
2024-12-30	BUY	200	82.670	83.440	83.363	USD 16,673	80.24
2024-12-06	BUY	160	83.320	83.720	83.680	USD 13,389	79.96
2024-12-05	BUY	40	83.090	84.130	84.026	USD 3,361	79.85
2024-12-04	BUY	200	84.410	85.920	85.769	USD 17,154	79.69
2024-11-29	BUY	200	85.610	86.000	85.961	USD 17,192	79.07
2024-11-27	BUY	160	85.290	85.740	85.695	USD 13,711	78.53
2024-11-26	BUY	40	84.530	84.920	84.881	USD 3,395	78.26
2024-11-25	SELL	-1,344	84.490	85.330	85.246	USD -114,571	77.96 Loss of -9,793 on sale
2024-11-21	BUY	220	84.910	85.010	85.000	USD 18,700	77.24
2024-11-20	BUY	132	83.590	83.910	83.878	USD 11,072	76.88
2024-11-18	BUY	528	81.830	82.390	82.334	USD 43,472	76.17
2024-11-12	BUY	352	83.420	83.510	83.501	USD 29,392	75.69
2024-11-08	BUY	220	80.880	81.900	81.798	USD 17,996	75.32
2024-11-07	BUY	660	81.970	82.930	82.834	USD 54,670	74.81
2024-11-06	BUY	88	82.710	84.870	84.654	USD 7,450	74.15
2024-10-31	BUY	44	73.540	74.720	74.602	USD 3,282	73.88

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of GMED

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	179,912	15,128	502,387	35.8%
2025-09-18	253,424	79	672,017	37.7%
2025-09-17	170,554	0	617,523	27.6%
2025-09-16	258,270	104	347,530	74.3%
2025-09-15	319,404	0	508,755	62.8%
2025-09-12	205,394	450	283,604	72.4%
2025-09-11	217,170	1,600	363,407	59.8%
2025-09-10	328,746	300	442,988	74.2%
2025-09-09	231,880	0	339,637	68.3%
2025-09-08	219,518	0	266,163	82.5%
2025-09-05	342,324	0	415,888	82.3%
2025-09-04	454,203	0	587,940	77.3%
2025-09-03	339,342	0	509,443	66.6%
2025-09-02	291,274	5	359,254	81.1%
2025-08-29	203,164	0	298,739	68.0%
2025-08-28	167,543	0	265,022	63.2%
2025-08-27	203,951	80	270,415	75.4%
2025-08-26	257,077	109	308,778	83.3%
2025-08-25	313,066	0	383,556	81.6%
2025-08-22	187,478	0	237,612	78.9%
2025-08-21	152,795	0	222,801	68.6%
2025-08-20	201,913	1,061	320,183	63.1%
2025-08-19	343,523	0	486,772	70.6%
2025-08-18	251,769	0	560,116	44.9%
2025-08-15	233,312	0	464,390	50.2%
2025-08-14	369,719	0	517,977	71.4%
2025-08-13	336,325	100	514,529	65.4%
2025-08-12	607,605	11	871,258	69.7%
2025-08-11	521,326	25	720,929	72.3%
2025-08-08	1,002,778	55	1,570,587	63.8%
2025-08-07	350,072	43	945,910	37.0%
2025-08-06	169,112	15	287,711	58.8%
2025-08-05	214,165	150	448,499	47.8%
2025-08-04	189,630	48	383,033	49.5%
2025-08-01	354,383	30	711,927	49.8%
2025-07-31	198,231	448	498,772	39.7%
2025-07-30	223,735	0	480,211	46.6%
2025-07-29	218,799	123	420,934	52.0%
2025-07-28	238,265	0	469,426	50.8%
2025-07-25	244,779	73	606,206	40.4%
2025-07-24	260,910	121	398,383	65.5%
2025-07-23	359,450	271	547,955	65.6%
2025-07-22	432,331	5,271	1,091,168	39.6%
2025-07-21	1,053,433	244	2,499,232	42.2%
2025-07-18	160,995	0	290,865	55.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE